Deutsche Bank’s HTG Molecular Diagnostics HTGM Stock Holding History
Bought
Maintained
Sold
Other funds holding HTGM
Deutsche Bank's HTGM Position: Q4 2019 in Review
Deutsche Bank sold out of HTG Molecular Diagnostics (HTGM) in Q4 2019, closing a stake of 99 shares — an estimated $11K sold.
Deutsche Bank first reported a position in HTGM in Q1 2016 and held it in 12 quarters. The position peaked at $61K in Q2 2016. 27 funds tracked by Wall St. Rank hold HTGM as of Q4 2019.
- Deutsche Bank reported no remaining HTG Molecular Diagnostics position as of Q4 2019 after selling out during the quarter.
- Deutsche Bank sold 99 HTG Molecular Diagnostics shares in Q4 2019, an estimated $11K.
- Deutsche Bank first reported a position in HTG Molecular Diagnostics in Q1 2016 and held it in 12 quarters.
- Deutsche Bank's HTG Molecular Diagnostics position peaked at $61K in Q2 2016.
- 27 funds tracked by Wall St. Rank held HTG Molecular Diagnostics as of Q4 2019.
Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.